Showing results (81-90 of 94) with videos related to

Sort By:
Pageof 10
Journal of Hepatology|December 12, 2001
S-Adenosylmethionine modulates inducible nitric oxide synthase gene expression in rat liver and isolated hepatocytesP L Majano, C García-Monzón, E R García-Trevijano, et al.
Alimentary Pharmacology & Therapeutics|February 28, 2002
Interferon-alpha plus ribavirin for 12 months increases the sustained response rates in chronic hepatitis C relapsersJ A Moreno-Monteagudo, A Castro, A De Pedro, et al.
The Journal of Experimental Medicine|March 1, 1994
Induction of tumor necrosis factor alpha production by human hepatocytes in chronic viral hepatitisR González-Amaro, C García-Monzón, L García-Buey, et al.
Alimentary Pharmacology & Therapeutics|June 29, 2006
Sustained virological response to peginterferon plus ribavirin in chronic hepatitis C genotype 1 patients is associated with a persistent Th1 immune responseM Trapero-Marugán, L García-Buey, C Muñoz, et al.
Scandinavian Journal of Gastroenterology|January 11, 2012
Evaluation of liver fibrosis by transient elastography (Fibroscan®) in patients with inflammatory bowel disease treated with methotrexate: a multicentric trialA Barbero-Villares, J Mendoza Jiménez-Ridruejo, C Taxonera, et al.
Hepato-Gastroenterology|December 5, 1998
Interferon alpha treatment of chronic hepatitis C in HIV-infected patients receiving zidovudine: efficacy, tolerance and response related factorsM A Del Pozo, J R Arias, J Pinilla, et al.
Alimentary Pharmacology & Therapeutics|April 12, 2000
Interferon alfa-2b plus ribavirin for chronic hepatitis C patients who have not responded to interferon monotherapyO Lo Iacono, A Castro, M Diago, et al.
Genes and Immunity|April 26, 2013
Polymorphisms in histone deacetylases improve the predictive value of IL-28B for chronic hepatitis C therapyR López-Rodríguez, Á Hernández-Bartolomé, M J Borque, et al.
Hepatology (Baltimore, Md.)|November 26, 1998
Chronic hepatitis C in children: a clinical and immunohistochemical comparative study with adult patientsC García-Monzón, P Jara, M Fernández-Bermejo, et al.
Clinical Pharmacology and Therapeutics|October 14, 2011
Genetic variants of interferon-stimulated genes and IL-28B as host prognostic factors of response to combination treatment for chronic hepatitis CR Lopez-Rodriguez, M Trapero-Marugan, M J Borque, et al.
Pageof 10